Mifamurtide for the treatment of osteosarcoma

NICE technology appraisals [TA235] Published date:

NICE recommends mifamurtide as a possible treatment for some children, adolescents and young adults with osteosarcoma.

Who can have mifamurtide?

Children, adolescents and young adults should be able to have mifamurtide if:

  • their tumour is high-grade and non-metastatic and
  • they have had an operation to remove the tumour and
  • they are also having chemotherapy with multiple drugs.
Why has NICE said this?

NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended mifamurtide because more people are cured if they have mifamurtide as well as chemotherapy, and the cost was justified by the benefits it provided.

Get involved